Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ROBERTS JOHN A Insider Profile
4 Followers
ROBERTS JOHN A, CEO at Cancer Genetics, holds 297.64K shares in Cancer Genetics (Ticker: CGIX). Most recently, ROBERTS JOHN A Bought $185,436 shares of Cancer Genetics on Feb 01, 2019 for an estimated value of 42.65K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-56.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO
Roles that ROBERTS JOHN A holds in companies
Most Profitable Insider Trade
The most profitable trade made by ROBERTS JOHN A
ROBERTS JOHN A's Trading History
List of latest transactions for each holding click on a transaction to see ROBERTS JOHN A's performance on stock
You May Also Like
ROBERTS JOHN A insider profile FAQ
What is the percentage of profitable transactions made by ROBERTS JOHN A?
The percentage of profitable transactions made by ROBERTS JOHN A is 0%.
What is the average return per transaction made by ROBERTS JOHN A?
The average return per transaction made by ROBERTS JOHN A is -56.60%.
What stocks does ROBERTS JOHN A hold?
ROBERTS JOHN A holds: CGIX stocks.
What was ROBERTS JOHN A’s latest transaction?
ROBERTS JOHN A latest transaction was an Informative Buy of $42.65K.
What was ROBERTS JOHN A's most profitable transaction?
ROBERTS JOHN A’s most profitable transaction was an Informative Buy of CGIX stock on January 16, 2019. The return on the trade was -37.40%.
What is ROBERTS JOHN A's role in Cancer Genetics?
ROBERTS JOHN A's role in Cancer Genetics is CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.